XML 44 R32.htm IDEA: XBRL DOCUMENT v3.4.0.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2016
Dec. 31, 2015
Shelf life of prescription products 24 months  
Related to Research and Development Activities [Member]    
Advance payments - total $ 1,005,503 $ 1,138,073
Advance payments - other assets current 941,054 1,009,175
Advance payments - long term prepaid expense $ 64,449 $ 128,898
Minimum [Member]    
Return period of unsalable prescription products 6 months  
Maximum [Member]    
Return period of unsalable prescription products 12 months